Directed shift of vaginal microbiota induced by vaginal application of sucrose gel in rhesus macaques  by Hu, Kai-tao et al.
International Journal of Infectious Diseases 33 (2015) 32–36Directed shift of vaginal microbiota induced by vaginal application
of sucrose gel in rhesus macaques
Kai-tao Hu1, Jin-xin Zheng 1, Zhi-jian Yu 1, Zhong Chen, Hang Cheng, Wei-guang Pan,
Wei-zhi Yang, Hong-yan Wang, Qi-wen Deng, Zhong-ming Zeng *
Department of Infectious Diseases and Shenzhen key lab for endogenous infection, Shenzhen Nanshan Hospital, Guangdong Medical College. No 89,
Taoyuan Road, Nanshan district, Shenzhen 518052, China
A R T I C L E I N F O
Article history:
Received 17 October 2014
Received in revised form 4 December 2014
Accepted 20 December 2014
Corresponding Editor: Eskild Petersen,
Aarhus, Denmark
Keywords:
Sucrose gel
Vaginal microbiota
Lactobacilli
Bacterial vaginosis
Rhesus macaques.
S U M M A R Y
Objectives: Sucrose gel was used to treat bacterial vaginosis in a phase III clinical trial. However, the
changes of vaginal ﬂora after treatment were only examined by Nugent score in that clinical trial, While
the vaginal microbiota of rhesus macaques is characterized by anaerobic, Gram-negative bacteria, few
lactobacilli, and pH levels above 4.6, similar to the microbiota of patients with bacterial vaginosis. This
study is aimed to investigate the change of the vaginal microbiota of rehsus macaques after topical use of
sucrose gel to reveal more precisely the bacterial population shift after the topical application of sucrose
gel.
Methods: Sixteen rhesus macaques were treated with 0.5 g sucrose gel vaginally and three with 0.5 g of
placebo gel. Vaginal swabs were collected daily following treatment. Vaginal pH levels and Nugent
scores were recorded. The composition of the vaginal micotbiota was tested by V3V4 16S rDNA
metagenomic sequencing. Dynamic changes in the Lactobacillus genus were analyzed by qPCR.
Results: The vaginal microbiota of rhesus macaques are dominated by anaerobic Gram-negative
bacteria, with few lactobacilli and high pH levels above 4.6. After ﬁve days’ treatment with topical
sucrose gel, the component percentage of Lactobacillus in vaginal microbiota increased from 1.31% to
81.59%, while the component percentage of Porphyromonas decreased from 18.60% to 0.43%, Sneathia
decreased from 15.09% to 0.89%, Mobiluncus decreased from 8.23% to 0.12%, etc.. The average vaginal pH
values of 16 rhesus macaques of the sucrose gel group decreased from 5.4 to 3.89. There were no
signiﬁcant changes in microbiota and vaginal pH observed in the placebo group.
Conclusions: Rhesus macaques can be used as animal models of bacterial vaginosis to develop drugs and
test treatment efﬁcacy. Furthermore, the topical application of sucrose gel induced the shifting of vaginal
ﬂora of rhesus macaques from a BV kind of ﬂora to a lactobacilli-dominating ﬂora.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-
nc-sa/4.0/).
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Sucrose gel has proven its efﬁcacy in a phase III clinical trial as a
novel option for a non-antibiotic-based treatment of bacterial
vaginosis (BV). Sucrose gel restores the normal vaginal ﬂora in BV
patients by promoting growth of protective lactobacilli and
suppressing the replication of pathogenic bacteria.1 Similar to* Corresponding author. No 89, Taoyuan Road, Nanshan district, 518052
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license (http://creativecommons.org/licenses/by-nc-sa/4.0/).other clinical studies on BV treatment, the clinical study on the use
of sucrose gel was conducted based on grading determined by
microscopic examination. Whether the Lactobacillus morphotypes
belonged to Lactobacillus or not was unconﬁrmed. The inﬂuence of
sucrose on the vaginal mcirobiota requires further study.
BV has a high rate of recurrence2 and threatens the health of
over 30% of women of childbearing age.3–5 The vaginal ﬂora of BV
patients is characterized by a lack of lactobacilli and a predomi-
nance of anaerobic pathogens such as Gardnerella vaginalis,
Atopobium vaginae and Prevotella spp., and often presents a high
vaginal pH above 4.8. Recent studies have provided robust
evidence demonstrating that the vaginal microbiota of rhesus
macaques is similar to that of human BV patients and might beciety for Infectious Diseases. This is an open access article under the CC BY-NC-SA
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of sucrose gel on the vaginal microbiota of rhesus macaques to
elucidate the mechanism of sucrose gel in the treatment of BV
patients.
2. Materials and Methods
2.1. Intervention, animal model and sample collection
The sucrose and placebo gels were produced as previously
reported.1 Brieﬂy, the main ingredient of the placebo gel was
xanthan gum, and the sucrose gel was prepared by adding 9%
sucrose to the placebo gel. All animal studies were approved by
the Institutional Animal Care and Use Committee (IACUC),
Nanshan Hospital, Guangdong Medical College. Female rhesus
macaques were provided by West China-Frontier PharmaTech Co.
(WCFP)/National Chengdu Center for Safety Evaluation of Drugs
(NCCSED), SPF (speciﬁc pathogen free), and were approximately
four years of age. Female rhesus macaques were included in the
study when vaginal conditions satisﬁed the criteria of human BV
diagnosis, including a baseline Nugent score >4, a high vaginal
ﬂuid pH (>4.8), few or lack of (1) leukocytes, (2) lactobacilli, (3)
Candida. After eliminating any data collected from menstruating
rhesus macaques, the sucrose gel group contained 16 monkeys,
and the placebo gel group contained three. Female rhesus
macaques in the sucrose gel group were administered with the
gel by syringe to the fornix of the vagina for ﬁve consecutive days
while the placebo gel group was administered with the placebo
gel. On study days one to six, vaginal samples were collected daily
to evaluate the Nugent score and measure pH levels. Vaginal
smears were observed by microscopy. Separate vaginal swabs
were collected for pH measurements and microscopy grading
examination.
2.2. Swab samples and DNA extraction
On study days one and six, quadruplicate vaginal swab
specimens were obtained and stored at -80 8C for 16S rDNA
V3V4 metagenomic sequencing and qPCR analysis. The head of
the sterile cotton swab collected for each specimen was cut and
placed into an eppendorf tube containing 1 mL PB. The tubes were
centrifuged for 10 min at 10,000 g to collect bacterial cells, and the
supernatant was discarded. Genomic DNA extraction was per-
formed using the QIAamp DNA mini kit (Qiagen, Germany) as
described.7
2.3. Illumina MiSeq sequencing, sequence processing and
classiﬁcation
The concentration of total DNA extracted from the vaginal
swabs was measured using a High Sensitivity Qubit (Life
Technologies Corporation, Carlsbad, CA). For each sample, three
50ul PCR mixes were prepared. The V3V4 region of the 16S rDNA
was then ampliﬁed through a polymerase chain reaction (PCR) as
previously reported.8,9 The samples and the negative template
control were then analyzed on an agarose gel (1% w/v in TAE
buffer) for quality control. The three PCR reactions were pooled and
45 mL of each pooled PCR reaction was puriﬁed using Agencourt
AMPure beads (Beckman Coulter, CA) according to the manufac-
turer’s instructions, with a ﬁnal elution in 15 mL of 10 TE buffer.
DNA concentration was measured using a Qubit kit (Invitrogen,
California, USA). The sample concentrations were adjusted and the
same total amount of each sample was used to perform Illumina
MiSeq sequencing with a standard amplicon kit according to the
300PE MiSeq protocol.9 300PE reads were further processed,
including denoising by clustering sequences with less than 3%dissimilarity using USEARCH10 and de novo chimera detection,
conducted with UCHIME v5.1.11 Taxonomic ranks were assigned to
each sequence using the Ribosomal Database Project (RDP) Naı¨ve
Bayesian Classiﬁer v.2.212 trained on the Greengenes database
(Oct, 2012 version),13 using 0.8 conﬁdence values as the cutoff.
Taxonomic classiﬁcation results for vaginal swabs are shown in
Figures 1 and 2 for 300PE MiSeq runs.
2.4. Quantitative Lactobacillus genus-speciﬁc real-time PCR Assays
The dynamic changes of the Lactobacillus genus as inﬂuenced by
sucrose were examined by quantitative PCR using a Lactobacillus
genus-speciﬁc forward primer (50-TGGAAACAGRTGCTAATACCG-
30) and reverse primer (50-GTCCATTGTGGAAGATTCCC-30) as
previously reported to quantify the copy number of Lactobacillus
16S rDNA in each sample.14 DNA was extracted as described above.
Each SybrGreen qPCR reaction mixture contained SybrGreen qPCR
Master Mix (2; ABI, USA), 12.5 mL (10 mM) each of forward and
reverse primers, and 1 mL of template DNA in a total volume of
25 mL. The thermocycling conditions for SybrGreen qPCR assays
were 95 8C for 10 min, followed by 25 cycles of 95 8C for 10 sec and
60 8C for 40 sec, with a ﬂuorescence read at 60 8C followed by a
melting curve analysis. The entire process was conducted on an ABI
StepOnePlus Real-Time PCR instrument. For the relative quantiﬁ-
cation of Lactobacillus genus, genomic DNA from L. fermentum was
extracted and quantiﬁed using a Qubit Kit (Invitrogen). The PCR
product from L. fermentum was used as positive control after gel
puriﬁcation and DNA sequencing veriﬁcation. Standard curves
were generated using ﬁve 10-fold dilutions of L. fermentum DNA
which ranged from 2.58104 to 2.58108 copies/mL. Assay results
were expressed as genome/gene lg10 copy numbers per 1 mL of
DNA. Negative controls were included in each PCR run.
2.5. Statistical analysis
Data were analyzed using IBM statistical SPSS 2.0 software.
Differences in bacteria scores (Table S1-S3) before and after
treatment were compared using the Mann-Whitney U Test.
Differences in the proportion of Lactobacillus DNA in all sequences
and the FQPCR assay result of the number of Lactobacillus DNA lg
copies before and after the treatment were compared using a
paired T test. A P value of less than 0.05 was considered to be
statistically signiﬁcant.
3. Results
3.1. Vaginal pH detection and microscopy grading
The vaginal pHs of animals treated with sucrose gel decreased
to below 4.6 in 14/16 animals by day three and by day ﬁve the
decrease was observed in all treated animals. In contrast, the
vaginal pHs of the placebo gel group rhesus macaques stayed
above 4.8 following treatment. Prior to treatment, the relative
abundance of non-lactobacilli bacteria (G.vaginalis, bacteroides and
Mobiluncus spp. morphotypes) dominated the vaginal ﬂora of all
rhesus macaques based on Nugent scores, suggesting a depletion of
lactobacilli in these models. By day ﬁve of sucrose gel treatment,
however, the number of lactobacilli gradually increased and
dominated the vaginal ﬂora (Fig 3A). Furthermore, the lactobacilli
score of the sucrose gel group was signiﬁcantly lower than before
treatment (P < 0.001, Table S1), and the G. vaginalis/bacteroides and
Mobiluncus score before treatment was higher than after treatment
(P < 0.001 and P < 0.05, respectively, Table S2 and S3). Based on
the Nugent scoring system, 93.8% (15/16) of the vaginal ﬂora of the
sucrose gel group became ‘‘normal’’ (Nugent score < 4) according
to the human criteria, suggesting that sucrose facilitates the
Figure 1. Average relative abundance of Illumina MiSeq sequencing reads assigned to phylum (chart A) and genus (chart B). The ﬁgure presents the average relative
abundance of 19 bacterial genera as detected by Illumina MiSeq sequencing of vaginal samples from the sucrose gel treatment group (G1, n = 16;) and the placebo gel group
(G2, n = 3).
Figure 2. The proportion of different kinds of bacterial genus under the different treatment conditions. The ﬁgure presents the average relative abundance of
19 bacterial genera as detected by Illumina MiSeq sequencing of vaginal samples from the sucrose gel treatment group (n = 16; A: before treatment, B: after treatment) and
the placebo gel group (n = 3, C: before treatment, D: after treatment).
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Figure 3. Gram-stain of vaginal ﬂora before and after gel treatment. The sucrose gel group is shown in (A) and the placebo group in (B) at day 0 and for 5 days following
treatment administration. Lactobacilli numbers increase gradually and dominate by day ﬁve with the application of sucrose gel while the placebo group maintains a vaginal
microﬂora characterized by a polymicrobial microbiota. Red arrows indicate lactobacilli.
K.- Hu et al. / International Journal of Infectious Diseases 33 (2015) 32–36 35propagation of lactobacilli in the vaginal region. In contrast, the
placebo gel groups maintained pre-treatment characteristics with
regard to the bacteria morphotypes and constitutions of vaginal
ﬂora (Fig 3B) and showed no signiﬁcant difference in Nugent score
(P > 0.05) following placebo gel treatment. This result conﬁrmed
that sucrose was effective and critical in the reconstruction of
‘‘normal vaginal ﬂora’’ in the animal models of BV.
3.2. Composition of vaginal microbiota as determined by Illumina
Miseq sequencing
Taxonomic composition of the vaginal microbiota in the sucrose
gel and control groups was investigated based on average relative
abundance of Illumina MiSeq sequencing reads assigned to
phylum (Fig 1, chart A) and genus(Fig 1, chart B). The proportion
of different kinds of bacterial genus is shown in detail in Fig
2. Before the treatment, the charts indicate a diverse array of
vaginal bacteria in the rhesus macaques, with abundant genera
and Lactobacillus representing less than 2% of all sequences.
Following 5 days of vaginal application of sucrose gel, Lactobacillus
dominated the vaginal ﬂora with 50.84% to 96.98% of sequences
identiﬁed as Lactobacillus. The relative abundance of Lactobacillus
in vaginal samples in the placebo gel group did not increase after
treatment, ranging from 0.06% to 10.96%.
3.3. Lactobacillus 16S rDNA copies in vaginal specimens
As shown in Figure S1, after 5 days of sucrose gel treatment, the
copy number of Lactobacillus in the sucrose gel treatment group
increased from 4.45  0.71 lg copies/mL to 6.02  0.30 lg copies/mL
after treatment, demonstrating a signiﬁcant increase (pair T test,
t = 7.702, P < 0.01). In contrast, the number of Lactobacillus DNA
copies in vaginal samples from the placebo gel group did not increase
after treatment.
4. Discussion
The vaginal ﬂora of rhesus macaques is characterized by a
polymicrobial microbiota. It is also suitable for growth of lactobacilli
including L. crispatus, L. jensenii and L. acidophilus, which also
colonize the human vagina.6,15 Gregory and colleagues found thatthe vaginal microbiota of rhesus macaques was similar to the ﬂora
found in BV patients.16 In this study, we examined the vaginal
microbiota of rhesus macaques based on the Nugent score standard
which is widely used to deﬁne BV. Our Illumina MiSeq sequencing
results in these animals before treatment further demonstrated that
the vaginal microbiota was similar to that in BV patients, suggesting
they could be used as animal models of BV. Traditionally,
metronidazole is used in BV treatment.16 As an antibiotic, however,
metronidazole inherently possesses the risks of adverse effects and
the potential risk of bacterial drug resistance.17–20 The sucrose gel is,
therefore, a novel non-antibiotic for treatment of BV. Phase III
clinical trials have shown its potential role in treating BV. It may
regulate the vaginal ﬂora of rhesus macaques and facilitate the
growth of Lactobacillus spp to obtain a ‘‘normal vaginal ﬂora’’.1 In this
study, we demonstrated that sucrose could decrease the vaginal pH
and alter the bacterial composition of the vaginal microbiota in an
animal model. The Illumine MiSeq system provides a powerful
sequencing platform for the rapid, high-throughput and in-depth
characterization of the microbial community composition using 16S
rDNA gene V3V4 region sequencing.9 The relative abundance of
Lactobacillus DNA in the sucrose gel treatment group ranged from
50.84% to 96.98%, signiﬁcantly increased (P < 0.01) compared with
the percentage ranging from 0.06% to 10.96% before treatment. In
contrast, the relative abundance of Lactobacillus DNA in the control
group did not change. Lactobacilli plays an important role in the
human vaginal ﬂora and is thought to be signiﬁcant in maintaining
the vaginal health of women owing to their probiotic characteristics
in inhibiting the growth of many pathogens including anaerobic
bacteria, fungi and viruses by competitive exclusion and/or through
the production of antimicrobial compounds, such as reuterin,
organic acids and/or hydrogen peroxide.15 Our data indicate that
sucrose may facilitate the growth of lactobacilli. Sucrose can also be
utilized by many bacteria in the vaginal region; however, in this
study, there was no increase in other bacteria following the sucrose
intervention, suggesting that sucrose advantageously promotes the
growth of lactobacilli. We hypothesize that, in the conditions found
in the vagina, lactobacilli can more effectively use sucrose. Why
lactobacilli have this advantage, however, requires further study.
Overall, our study indicates that rhesus macaques can be used
as BV animal models to develop drugs and test treatment efﬁcacy.
Sucrose gel showed good efﬁcacy in this model to treat BV by
K.- Hu et al. / International Journal of Infectious Diseases 33 (2015) 32–3636improving the Nugent Score and vaginal microbiota by promoting
growth of Lactobacillus species. Further studies need to be
performed to determine the mechanism by which lactobacilli
preferentially propagate in the presence of sucrose.
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